Randeep Guleria

Randeep Guleria is an Indian pulmonologist and the current director of the All India Institute of Medical Sciences, New Delhi,[1][2] credited with the establishment of India's first centre for pulmonary medicines and sleep disorders at AIIMS.[3] He was honoured by the Government of India in 2015 with Padma Shri, the fourth highest Indian civilian award.[4] He is a part of India's COVID-19 response effort.

Randeep Guleria
Dr. Randeep Guleria.jpg
Born (1959-04-05) 5 April 1959 (age 62)
Alma materIndira Gandhi Medical College, PGIMER
OccupationDirector, AIIMS, Delhi Pulmonologist
Years active1997-present
Spouse(s)Dr. Kiran Guleria
AwardsPadma Shri
Dr. B. C. Roy Award

Guleria is co-author of book Till We Win: India's Fight Against The COVID-19 pandemic, with Chandrakant Lahariya, a leading Indian public policy and health system expert and Gagandeep Kang of Christian Medical College, Vellore.


An honest approach to life and a complete devotion to my job is what spiritualism means to me. I have great faith in the Almighty, and so, I consider myself spiritual, says Randeep Guleria.[5]

Dr Guleria started his medical studies at IGMC, Shimla, affiliated to Himachal Pradesh University from where he received undergraduate degree in Medicine,[6] afterwards he attended the Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, from where he secured his MD in general medicine and DM in pulmonary medicine.[7][8] He joined the All India Institute of Medical Sciences and rose in ranks to become a professor and the head of the department of Pulmonology and Sleep Disorders.[7] He is associated with the World Health Organization (WHO) as a member of its Scientific Advisory Group of Experts (SAGE)[9] on immunization and influenza vaccination.[7][8] He is a life member of the Association of Physicians of India, Indian Chest Society and the National College of Chest Physicians of India.[7] He also serves as a consultant to International Atomic Energy Agency (IAEA), Vienna on issues related to radiation protection.[7][8]

Guleria was the personal physician to Atal Bihari Vajpayee, former Prime Minister of India since 1998[8] and is credited with research on pulmonary diseases.[7][10] His research findings have been recorded by way of 36 book chapters and 268 articles;[7][8][11] ResearchGate, an online knowledge repository has published 117 of them.[12] He is credited with efforts in establishing a centre for respiratory diseases and sleep medicine at AIIMS, which is reported to be a first in India.[3] He is a recipient of Raj Nanda Pulmonary Disease Fellowship from Raj Nanda Trust and the Royal College of Physicians, UK[7][8] and is an elected fellow (2011) of the National Academy of Medical Sciences (NAMS).[13] He sits on the editorial boards of a number of medical journals such as the Indian Journal of Chest Diseases, Lung India, JAMA: The Journal of the American Medical Association and Chest India.[8]

Randeep Guleria was included by the Government of India in the 2015 Republic Day honours list for the civilian award of Padma Shri.[4] He lives in Delhi, adjacent to the AIIMS campus.[14]

He has been awarded the prestigious Dr. B C Roy National Awards for the year 2014, under eminent medical person category by the Medical Council of India.[15] He is regarded as one of India's leading medical expert.[16][17][18] He is an alumnus of St. Columba's School, Delhi.[citation needed]

Till We Win: The BookEdit

Till We Win: India’s fight against the COVID-19 Pandemic is a book authored by Chandrakant Lahariya, Gagandeep Kang and Randeep Guleria. The book became national bestseller within first week of release (The Asian Age National bestseller list ; 20 Dec 2020). This book provides unique blend of information on macro (health policy) as well as micro (how to stay safe in and during pandemic period) issues. The 352 page book has sections on viruses, why pandemic happens; India’s response to pandemic before and during lockdowns and unlock periods, key learnings for health sector during these periods. There are detailed sections which provide useful information on COVID-19 vaccines as well as therapies. One chapter is devoted on how to strengthen India’s healthcare system. The book has been published by India's leading publisher Penguin Random House India and has become a bestseller. The book has been termed as "An easy to read and an important book driven by science, data and reason' by the editor in chief of India's leading newspaper the Hindustan Times.

A key feature of the books is frequently asked questions which features in most of the chapters and answer common queries and concerns about the COVID-19 by the general public. The last chapter is focused on general public and deals with how to stay healthy through 2-3--3-4 approach’. There is specific approach for mental and social health called ‘1-2-3 approach or learn – connect – well’. There are specific tips in the book for those who have recovered from COVID-19. Written by three of India’s leading medical experts who are at the helm of COVID-19 pandemic response, it is not surprising that the book has been recommended by nearly all major newspapers The Deccan Herald, The Pioneer and The Times of India; and journals as essential reading for 2021.

See alsoEdit


  1. ^ "AIIMS Pulmocrit". AIIMS Pulmocrit. 2015. Retrieved 21 February 2015.
  2. ^ "Randeep Guleria appointed as new AIIMS director". Retrieved 1 April 2017.
  3. ^ a b Chatterjee, Pritha (21 June 2011). "India's first centre for pulmonary medicine, sleep disorders soon". The Indian Express. Retrieved 9 July 2018.
  4. ^ a b "Padma Awards". Padma Awards. 2015. Archived from the original on 26 January 2015. Retrieved 16 February 2015.
  5. ^ Randeep Guleria (as told to Soumi Dey) (July 2010). "I Am". Times of India.
  6. ^ "IGMC-Shimla". www.igmcshimla.edu.in. Retrieved 3 June 2020.
  7. ^ a b c d e f g h "Sehat". Sehat. 2015. Retrieved 21 February 2015.
  8. ^ a b c d e f g "Daiichi Sankyo India". Daiichi Sankyo India. 2015. Retrieved 21 February 2015.
  9. ^ "SAGE". SAGE. 2015. Retrieved 21 February 2015.
  10. ^ "CTRI". Clinical Trials Registry of India. 15 September 2010. Retrieved 21 February 2015.
  11. ^ Randeep Guleria. "Radiation Exposure in Medicine - Do Doctors Know Enough?" (PDF). AIIMS Circular.
  12. ^ "Profile on ResearchGate". 2015. Retrieved 21 February 2015.
  13. ^ "NAMS" (PDF). NAMS. 2015. Retrieved 21 February 2015.
  14. ^ "Down to Earth". Down to Earth. 11 December 2014. Retrieved 21 February 2015.
  15. ^ "Prez honours AIIMS chief Randeep Guleria with Dr. B C Roy award". Retrieved 1 April 2017.
  16. ^ https://www.tribuneindia.com/news/nation/covid-cases-havent-yet-peaked-or-even-plateaued-aiims-director-125556
  17. ^ https://www.indiatoday.in/india/story/safety-of-russia-s-covid-vaccine-needs-to-be-assured-says-aims-director-randeep-guleria-1710155-2020-08-11
  18. ^ https://indianexpress.com/article/explained/dr-randeep-gulleria-coronavirus-covid-19-india-cases-6502680/

Further readingEdit

External linksEdit